Skip to main content
Clinical Trials/NCT00520026
NCT00520026TerminatedNot Applicable

Suicide Prevention by Lithium - the Lithium Intervention Study

University Hospital Schleswig-Holstein5 sites in 1 country167 target enrollmentStarted: January 2001Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Not Applicable
Status
Terminated
Sponsor
Enrollment
167
Locations
5
Primary Endpoint
occurrence of attempted and completed suicides

Study Overview

Brief Summary

The purpose of this study is to examine the proposed suicide preventive effects of lithium in a randomized controlled trial within a group of individuals with depressive disorders. The hypothesis being tested is that lithium treatment will significantly reduce the risk for another suicide attempt.

Detailed Description

Several studies have shown that there is a significantly increased risk of suicide related mortality in patients with a positive history of suicide attempts. This study is the first prospective, randomized, double-blind, placebo controlled multi-center trial focussing on the proposed suicide preventive effects of lithium in patients with suicidal behavior but not suffering from bipolar disorder or recurrent major depressive disorder. Patients with a recent history of a suicide attempt are treated with lithium or placebo during a 12 month-period. The hypothesis is that lithium treatment will lead to a 50 % reduction of suicidal behavior.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
Triple (Participant, Care Provider, Investigator)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • suicide attempt within 3 months prior to the first drug administration
  • occurrence of suicide attempt within the context of an affective spectrum disorder
  • minimum age of 18 years
  • ability to complete screening and baseline assessment
  • ability to understand and provide informed consent

Exclusion Criteria

  • diagnosis of schizophrenia, borderline personality disorder, substance related disorders
  • indication for long-term lithium treatment
  • thyroid disease
  • pregnancy and lactation

Arms & Interventions

1

Active Comparator

Lithium treatment

Intervention: lithium (Drug)

2

Placebo Comparator

Placebo treatment

Intervention: placebo (Drug)

Outcomes

Primary Outcomes

occurrence of attempted and completed suicides

Time Frame: follow-up period of 1 year

Secondary Outcomes

  • Specific aspects of the suicide attempt/completed suicide(follow-up period of 1 year)

Investigators

Sponsor
University Hospital Schleswig-Holstein
Sponsor Class
Other

Study Sites (5)

Loading locations...

Similar Trials